← Eichor
Study identifier: NCT07701135 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Antimicrobial Stewardship Effects of Interpretive Comments for Faecal PCR Tests

Condition: Gastroenteritis Acute · Diagnostic Communication  ·  Sponsor: Medical Research Institute of New Zealand

PhaseNA
Planned participants10000
Who can joinAll sexes, 6 Months to no upper limit
Healthy volunteersNo

About this study

Bacterial gastroenteritis is a common condition seen in Aotearoa New Zealand, which is typically diagnosed by PCR testing on a stool sample. Most causes of bacterial gastroenteritis (e.g. Campylobacter spp, Salmonella spp, Yersinia spp) cause a self-limiting illness and antibiotic therapy is not required. Indeed, guidelines available for community healthcare providers in Aotearoa (e.g. Community HealthPathways, recently released national antimicrobial guidelines Te Whata Kura) recommend against antibiotic therapy for the vast majority of cases. A recent internal analysis at Awanui Laboratories of community faecal pathogen PCR testing revealed that antibiotic prescribing was very common after a positive result (ranging between 20-40% for the various individual pathogens), which suggests many community healthcare providers may not be following the recommended approach for the management of these infections. Given how common infectious gastroenteritis is in Aotearoa, and the volume of tests performed (approximately 100,000 through the Awanui network per year), this prescribing behaviour may represent a large volume of unnecessary antibiotic use in our communities, with resultant potential harmful effects at the individual patient level and population level via side effects, disruption to the faecal microbiome, and impacts on antimicrobial resistance (AMR). In previous work we have demonstrated that interpretive comments, when added to laboratory reports, can have a significant…

This description comes directly from the study's public registry record.

Talk to the study team

Max Bloomfield, MBChB  ·  +64272089584  ·  maxim.bloomfield@ccdhb.org.nz

Always discuss trial participation with your own doctor first.

Locations (4)

Awanui Labs AucklandAuckland, New ZealandRecruiting
Awanui Labs ChristchurchChristchurch, New ZealandRecruiting
Awanui Labs DunedinDunedin, New ZealandRecruiting
Awanui Labs WellingtonWellington, New ZealandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07701135